Randomized Study of Decitabine in Maintenance Therapy of Acute Myeloid Leukemia (AML)

Clinical trial NCT00398983 · COMPLETED

Trial details

NCT number: NCT00398983
Sponsor: M.D. Anderson Cancer Center
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Acute Myelogenous Leukemia

Start date: 2006-08-01
Primary completion: 2012-05-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.